An observational study on efficacy of atrioventricular nodal slow pathway ablation in patients with atrioventricular nodal reentrant tachycardia and its influence on atrioventricular conduction function
Hongwei Wang,Xiumei Li
DOI: https://doi.org/10.1097/md.0000000000040532
IF: 1.6
2024-11-28
Medicine
Abstract:Supraventricular tachycardia (SVT), a heterogeneous group of rapid arrhythmias, is primarily attributed to ectopic foci or reentrant circuits positioned superior to the bifurcation of the His bundle. [ 1 ] SVT can be stratified into multiple subtypes, such as atrioventricular nodal reentrant tachycardia (AVNRT), sinus tachycardia, atrial fibrillation, focal atrial tachycardia, and atrioventricular reentrant tachycardia, based on the site of abnormality within the conduction system and the pathophysiological principles involved. Notably, AVNRT represents approximately 50% to 60% of all SVT instances. [ 2 , 3 ] AVNRT predominantly afflicts young to middle-aged adults, often manifesting with symptoms such as restlessness, palpitations, angina, and agitation, and it may precipitate shock in severe cases. [ 4 ] At present, the underlying pathogenesis of AVNRT remains incompletely understood. However, it is generally posited that anomalies in the development of the congenital cardiac conduction pathway and functional dissociation within the atrioventricular node play significant roles. [ 5 , 6 ] Traditional management strategies for AVNRT primarily encompass pharmacological interventions (with a focus on beta-blockers and calcium channel blockers), physical therapies, and electrical cardioversion. While these approaches can yield moderate efficacy, their significant limitation lies in the high recurrence rates observed posttreatment.
medicine, general & internal